8.3 Hyperbaric Oxygen Therapy (HBOT): Mechanisms, Indications & Safety

8.3 Hyperbaric Oxygen Therapy (HBOT): Mechanisms, Indications & Safety

Core Clinical Principle: Hyperbaric Oxygen Therapy (HBOT) is an advanced systemic medical intervention in which a patient breathes 100% oxygen at ambient pressures greater than 1.0 atmosphere absolute (ATA), typically between 2.0 and 2.4 ATA. By exploiting the physical solubility of gases in liquids, HBOT supersaturates blood plasma with dissolved oxygen, overcoming severe microvascular diffusion barriers to reignite stalled cellular bioenergetics, collagen synthesis, angiogenesis, and antimicrobial defenses.

HBOT is not merely a method of oxygenating tissue; it functions as a potent pharmacological signal. Intermittent hyperoxia induces profound genomic and post-translational cascades, mobilizing progenitor stem cells, modulating cytokines, and restoring leukocyte bactericidal capacity in critically hypoxic tissue beds.

---

Biophysics & Gas Laws: Henry's Law & Dissolved Plasma Oxygen

The physiological effects of HBOT are governed by fundamental physical gas laws:

• Boyle's Law ($P_1 V_1 = P_2 V_2$): At constant temperature, the volume of a gas is inversely proportional to its pressure. As chamber pressure increases during descent, gas volumes in closed anatomical cavities decrease; during ascent (decompression), expanding gas volume can produce barotrauma if egress is blocked.
• Dalton's Law ($P_{\text{total}} = \sum P_i$): The total pressure of a gas mixture equals the sum of the partial pressures of each individual gas component ($P_i = P_{\text{total}} \times \text{fractional concentration}$).
• Henry's Law ($C = k \cdot P$): The concentration of a gas dissolved in a liquid is directly proportional to the partial pressure of that gas above the liquid.

Quantitative Hemodynamics of Hyperoxia

Under normal physiological conditions at sea level (1.0 ATA) breathing ambient room air (21% $O_2$):

• Arterial oxygen tension ($p_aO_2$) is approximately 100 mmHg.
• Circulating hemoglobin (Hb) is 97% to 98% saturated, binding approximately 19.8 mL of $O_2$ per 100 mL (dL) of blood ($1.34\text{ mL } O_2/\text{g Hb} \times 15\text{ g/dL} \times 0.98$).
• In sharp contrast, the oxygen dissolved directly in physical solution in blood plasma is negligible, totaling only 0.3 mL of $O_2$ per dL of blood (calculated via the solubility coefficient of oxygen in plasma: $0.0031\text{ mL } O_2/\text{dL}/\text{mmHg} \times 100\text{ mmHg} = 0.31\text{ mL/dL}$).

When placed inside a hyperbaric chamber at 2.4 ATA breathing 100% $O_2$:

• Alveolar and arterial $pO_2$ surge to approximately 1,700 to 1,800 mmHg (after accounting for alveolar water vapor pressure [47 mmHg] and carbon dioxide [40 mmHg]).
• Hemoglobin becomes 100% saturated (binding ~20.1 mL $O_2$/dL).
• Crucially, the amount of oxygen dissolved physically in plasma increases by 20-fold, reaching 5.6 to 6.0 mL of $O_2$ per dL of blood ($0.0031 \times 1800 \approx 5.6\text{ to }6.0\text{ mL/dL}$).

THE HEMODYNAMIC MIRACLE OF HENRY'S LAW
==================================================================================
Basal Resting Cellular Extraction:
  Average resting whole-body tissue oxygen consumption by human cells equals:
  --> 5.0 to 6.0 mL of O2 per deciliter of circulating blood.

At 2.4 ATA Breathing 100% Oxygen:
  --> Dissolved O2 in plasma = ~6.0 mL / dL of blood.

Physiological Consequence:
  The dissolved oxygen in plasma alone is completely sufficient to meet all basal
  resting cellular metabolic requirements of the body WITHOUT NEEDING ANY OXYGEN
  UNLOADED FROM HEMOGLOBIN! Even in areas where red blood cells cannot traverse
  due to microvascular sludging, severe edema, or capillary occlusions, plasma carrying
  dissolved oxygen can diffuse across tissue beds up to 3 to 4 times farther than normal.
==================================================================================

---

Cellular & Biochemical Mechanisms of Hyperbaric Oxygen

HBOT overcomes critical tissue hypoxia ($pO_2 < 30\text{ mmHg}$) to drive several vital repair pathways:

1. Collagen Synthesis & Matrix Hydroxylation

Fibroblasts require molecular oxygen to manufacture and secrete structural collagen. In severe hypoxia ($pO_2 < 20\text{ mmHg}$), fibroblast collagen production is completely arrested.

• Hydroxylation Reactions: Molecular oxygen is an obligatory, rate-limiting co-substrate for prolyl 4-hydroxylase and lysyl hydroxylase (which also require ferrous iron [$Fe^{2+}$], $\alpha$-ketoglutarate, and ascorbic acid [vitamin C]). Hydroxylation of proline residues is indispensable for assembling and stabilizing the triple-helical structure of procollagen.
• Extracellular Cross-Linking: Hydroxylysine residues undergo oxidative deamination by lysyl oxidase, an oxygen-dependent extracellular enzyme that generates covalent intermolecular cross-links between adjacent tropocollagen helices. This cross-linking establishes mature fibrillar tensile strength. Maximal collagen production and cross-linking occur at tissue $pO_2$ levels between 200 and 400 mmHg.

2. Neovascularization & Angiogenic Signaling

While chronic, persistent hypoxia paralyzes tissue repair, intermittent hyperoxia stimulates dynamic neovascularization:

• The Hyperoxic-Hypoxic Gradient: HBOT creates steep, transient oxygen gradients between perfused hyperoxic margins and the hypoxic wound core. This cyclic variation acts as a powerful stimulus for wound macrophages to synthesize and release Vascular Endothelial Growth Factor (VEGF-A) and basic fibroblast growth factor (bFGF).
• Endothelial Progenitor Cell (EPC) Mobilization: Hyperoxia activates endothelial nitric oxide synthase (eNOS) within bone marrow stroma via phosphorylation. The resulting burst of nitric oxide (NO) stimulates the release of membrane-bound kit-ligand, triggering the mobilization of CD34+/VEGFR-2+ endothelial progenitor cells (EPCs) from the bone marrow into circulating peripheral blood. These circulating EPCs home to sites of ischemic tissue injury along stromal cell-derived factor-1 (SDF-1 / CXCR4) gradients, directly incorporating into sprouting capillary sprouts.

3. Leukocyte Bactericidal Capacity (Oxidative Burst)

Polymorphonuclear neutrophils (PMNs) eliminate bacteria primarily via oxygen-dependent intracellular killing:

• NADPH Oxidase Activation: Upon phagocytosis of bacteria, neutrophils activate membrane-bound NADPH oxidase (the respiratory burst enzyme complex), transferring electrons from NADPH to molecular oxygen to generate superoxide radicals ($O_2^{\bullet-}$).
• Secondary Reactive Oxygen Species (ROS): Superoxide is converted by superoxide dismutase (SOD) into hydrogen peroxide ($H_2O_2$). In the presence of chloride ions, myeloperoxidase (MPO) converts $H_2O_2$ into hypochlorous acid ($HOCl$), a lethal bactericidal agent that dissolves microbial cell walls.
• Hypoxic Paralysis: At tissue $pO_2$ levels below 30 mmHg (common in infected diabetic foot ulcers and irradiated tissues), neutrophil oxidative burst is paralyzed, leaving the host defenseless against microbial proliferation. HBOT restores tissue oxygen tension above critical thresholds (30–40 mmHg), reinstating lethal neutrophil bactericidal function against Staphylococcus aureus, Pseudomonas aeruginosa, and Enterobacteriaceae.

4. Direct Antimicrobial Effects Against Anaerobes

• Direct Bactericidal Activity: Obligate anaerobic pathogens (e.g., Bacteroides fragilis, Clostridium species) lack endogenous antioxidant defense enzymes (superoxide dismutase, catalase, and glutathione peroxidase). Exposure to hyperoxia generates lethal concentrations of toxic free oxygen radicals, causing rapid bacterial membrane peroxidation and DNA fragmentation.
• Alpha-Toxin Suppression in Gas Gangrene: In clostridial myonecrosis (Clostridium perfringens), the primary lethal agent is the necrotizing alpha-toxin (lecithinase / phospholipase C), which lyses host cell membranes and produces widespread myonecrosis and shock. When tissue $pO_2$ rises above 250 mmHg, C. perfringens transcription of alpha-toxin is immediately halted. While HBOT does not eliminate the need for surgical debridement, it halts active tissue destruction and systemic toxin spread.

5. Edema Reduction & Microvascular Decoupling

Hyperoxia induces immediate reflex precapillary arteriolar vasoconstriction, decreasing peripheral arterial inflow by approximately 20%. Under normal conditions, vasoconstriction would worsen tissue hypoxia. However, because dissolved plasma oxygen increases 20-fold under 2.4 ATA, tissue oxygen delivery is maintained at supraphysiologic levels despite diminished blood flow. This unique decoupling of perfusion from oxygen delivery reduces microvascular capillary hydrostatic pressure, diminishing third-space fluid extravasation, resolving severe compartment edema, and restoring post-capillary venular patency.

---

UHMS Approved Indications vs. CMS NCD 20.29 Guidelines

The Undersea and Hyperbaric Medical Society (UHMS) is the international scientific authority that evaluates clinical evidence and designates official on-label indications for hyperbaric oxygen therapy. Currently, the UHMS recognizes 14 approved indications:

THE UHMS 14 APPROVED CLINICAL INDICATIONS FOR HBOT
==================================================================================
 1. Air or Gas Embolism (Arterial Gas Embolism / AGE)
 2. Carbon Monoxide Poisoning (and CO complicated by Cyanide Poisoning)
 3. Clostridial Myositis and Myonecrosis (Gas Gangrene)
 4. Crush Injury, Compartment Syndrome, and other Acute Traumatic Ischemias
 5. Decompression Sickness ("The Bends")
 6. Arterial Insufficiencies:
    a. Central Retinal Artery Occlusion (CRAO)
    b. Selected Problem Wounds (Diabetic Foot Ulcers Wagner Grade 3+)
 7. Severe Exceptional Blood Loss Anemia (when transfusion is impossible or refused)
 8. Intracranial Abscess (subdural and epidural empyema, brain abscess)
 9. Necrotizing Soft Tissue Infections (Necrotizing Fasciitis, Fournier Gangrene)
10. Delayed Radiation Injury (Soft Tissue Radionecrosis & Osteoradionecrosis)
11. Refractory Osteomyelitis (chronic, non-responsive to surgery & IV antibiotics)
12. Compromised Skin Grafts and Flaps (threatened microvascular salvage)
13. Acute Thermal Burn Injury
14. Idiopathic Sudden Sensorineural Hearing Loss (ISSHL)
==================================================================================

Regulatory Divergence: UHMS vs. CMS Medicare Reimbursement

While UHMS establishes scientific validity for all 14 indications, the Centers for Medicare & Medicaid Services (CMS) National Coverage Determination (NCD 20.29) reimburses only a specific subset under Medicare Part B. Crucially, The NCD lists thermal skin burns and exceptional blood loss anemia among non-covered conditions, and it does not list idiopathic sudden sensorineural hearing loss or intracranial abscess as covered indications. Understanding this distinction between clinical efficacy (UHMS) and federal reimbursement (CMS) is essential for physician practice.

1. Diabetic Foot Ulcers: The Wagner Grade 3 Mandate

CMS reimbursement for diabetic foot ulcers under NCD 20.29 is governed by rigorous, non-negotiable criteria:

• Wagner Grade 3 or Higher: The ulcer must penetrate into deep subcutaneous tissues and involve exposed bone, tendon, joint capsule, deep abscess, or active osteomyelitis.
  • Wagner Grade 1 (superficial ulcer) and Wagner Grade 2 (deep ulcer extending to tendon/capsule without infection/abscess/bone involvement) are explicitly non-covered by CMS.
• 30-Day Standard Care Requirement: The wound must show no measurable signs of healing for at least 30 consecutive days of adequate standard wound therapy before HBOT is covered, and HBOT is given in addition to standard care. Coverage for continued treatment ends if measurable healing is not seen during any 30-day period of HBOT. Standard care must document: (1) surgical sharp debridement to remove necrotic tissue, (2) offloading via total contact casting or validated devices, (3) glycemic control (HbA1c optimization), (4) objective vascular assessment, (5) appropriate infection management, and (6) moist wound dressings.
• Transcutaneous Oximetry (TcPO2) Responsiveness: Pre-treatment room-air TcPO2 values < 30–40 mmHg confirm baseline tissue hypoxia. In-chamber testing breathing 100% $O_2$ demonstrating an elevation of TcPO2 > 200 mmHg confirms microvascular responsiveness and predicts favorable ulcer healing.

2. Chronic Refractory Osteomyelitis

Defined as persistent or recurrent bone infection that has failed to resolve despite:

1. At least one definitive surgical debridement to remove necrotic sequestrum, AND
2. At least 6 weeks of culture-directed parenteral (IV) antibiotic therapy. HBOT acts synergistically with aminoglycosides and fluoroquinolones (whose active transport across bacterial membranes is an oxygen-dependent process) and promotes osteoclast-mediated clearance of necrotic bone.

3. Radiation-Induced Tissue Injury: The Marx Protocol

Radiation therapy causes progressive obliterative endarteritis, microvascular thrombosis, and stromal fibrosis, resulting in tissues that are chronically hypocellular, hypovascular, and hypoxic (the Marx "3-H" principle). This leads to soft tissue radionecrosis (STRN; radiation cystitis, radiation proctitis, radiation-induced soft tissue breakdown) or osteoradionecrosis (ORN; primarily of the mandible):

• The Marx Protocol for Mandibular ORN:
  • Pre-operative Phase: 30 daily hyperbaric sessions (dives) at 2.4 ATA for 90 minutes of 100% $O_2$ to stimulate angiogenesis and cellularity in the irradiated surgical field.
  • Surgical Intervention: Radical surgical debridement, tooth extraction, or free-flap bone reconstruction.
  • Post-operative Phase: 10 daily dives at 2.4 ATA immediately following surgery to support microvascular integration and wound closure.
  • Total course: 40 sessions. In Marx staging, stage I patients who improve after 30 sessions complete about 10 more; stage II adds surgical debridement with 10 post-operative sessions; and stage III (pathologic fracture, orocutaneous fistula, or lysis to the inferior border) receives 30 sessions, resection, and 10 post-operative sessions.
  • Prophylaxis ("20/10"): For dental extraction in an irradiated mandible, Marx used 20 sessions before and 10 after surgery. A later randomized trial (HOPON, 2019) did not show a clear benefit of HBOT for preventing ORN after extractions, so this use is debated.

4. Compromised Skin Grafts and Flaps

Indicated for the salvage of threatened or failing tissue transfers where localized microvascular insufficiency, pedicle compromise, or venous congestion places the graft or flap at imminent risk of total necrosis. HBOT is not indicated for normal, uncompromised elective skin grafts or flaps.

---

Clinical Protocols, Dive Parameters & Chamber Systems

HBOT is administered in two primary chamber configurations:

• Monoplace Chamber: A single-occupant acrylic cylindrical vessel pressurized entirely with 100% medical-grade oxygen. The patient breathes the chamber atmosphere directly without a mask. If an air break is indicated, the patient breathes room air via a demand valve mask.
• Multiplace Chamber: A large steel or acrylic vessel accommodating multiple patients (and medical staff). The chamber is pressurized with compressed ambient air, and patients breathe 100% oxygen via a tightly sealed plastic hood, tight-fitting oronasal mask, or endotracheal tube.

STANDARD CLINICAL DIVE PROFILE (2.4 ATA Wound Protocol)
==================================================================================
Pressure Plateau: 2.4 ATA (equivalent to 45 feet of seawater / 14 meters of seawater)
Duration: 90 minutes of 100% Oxygen breathing, broken down into:
  [20-25 min Compression] -> [30 min O2] -> [5 min AIR BREAK] ->
  [30 min O2] -> [5 min AIR BREAK] -> [30 min O2] -> [15-20 min Decompression]
Total Chamber Time: Approximately 115 to 120 minutes per session.
Treatment Frequency: Once daily, 5 days per week, for a typical total of 30 to 40 sessions.
==================================================================================

The Mandatory 5-Minute Air Break

During the 90-minute oxygen breathing plateau, patients are administered 5-minute air breaks (breathing room air) every 30 minutes. Interspersing brief periods of normoxia allows accumulated cellular reactive oxygen species and oxidized glutathione in cerebral tissues to clear, dramatically reducing the incidence of central nervous system (CNS) oxygen toxicity without sacrificing overall therapeutic tissue oxygenation.

---

Contraindications & Drug-Drug Interactions

Absolute Contraindication: Untreated Pneumothorax

Untreated pneumothorax is the sole absolute contraindication to HBOT!

• Biophysical Mechanism: Trapped air inside a closed pleural space will compress during chamber pressurization (Boyle's Law). However, during decompression at the end of the dive, ambient pressure drops precipitously, causing the trapped intrapleural air to expand explosively ($V_2 = P_1 V_1 / P_2$). This converts a simple closed pneumothorax into a fatal tension pneumothorax, leading to mediastinal shift, complete vena caval compression, obstructive shock, and catastrophic arterial gas embolism (AGE).
• Mandate: A patient with a known or suspected pneumothorax must undergo tube thoracostomy (chest tube placement) and pleural decompression prior to entering a hyperbaric chamber.

Relative Contraindications & Critical Pharmacological Hazards

---

Complications, Toxicities & Emergency Seizure Management

1. Middle Ear Barotrauma (Barotitis Media)

The most frequent complication of HBOT, occurring in 10% to 20% of patients. During chamber compression (descent), increasing ambient pressure compresses gas within the middle ear cavity according to Boyle's Law. If the Eustachian tube fails to open to equalize pressure, inward retraction of the tympanic membrane occurs, leading to pain, edema, hemotympanum, or membrane perforation (graded using the Teed classification, Grades 0 to 5).

• Prevention & Management: Patients are trained in autoinflation maneuvers (Valsalva, Toynbee, swallowing). Topical nasal vasoconstrictors (oxymetazoline) or oral decongestants (pseudoephedrine) may be administered. If equalization remains impossible, bilateral tympanostomy (myringotomy) tubes must be surgically placed.

2. Transient Hyperoxic Myopia

Repeated hyperbaric oxygen dives induce reversible structural alterations in the crystalline lens, causing an increased refractive index and a progressive myopic shift (nearsightedness) of 0.5 to 2.0 diopters. The condition is benign and completely reverses within 6 to 12 weeks following cessation of HBOT. Patients must be cautioned not to purchase new corrective lenses during or immediately following therapy.

3. Pulmonary Oxygen Toxicity (The Lorrain Smith Effect)

Results from prolonged exposure to elevated oxygen partial pressures over dozens of cumulative hours. Excessive reactive oxygen species cause tracheobronchial mucosal inflammation, characterized by sub-sternal burning chest pain, persistent dry cough, dyspnea, and progressive reduction in vital capacity. It is prevented by adhering to standard 90-minute protocols with 5-minute air breaks.

4. Central Nervous System (CNS) Oxygen Toxicity (The Paul Bert Effect)

CNS oxygen toxicity occurs when hyperbaric oxygen produces cerebral capillary vasoconstriction failure, generating excessive ROS that overwhelm neuronal glutathione defenses and trigger generalized epileptic seizures.

• Premonitory Symptoms (Mnemonic: VENTID):
  • V – Visual disturbances (tunnel vision, flashes, blurring)
  • E – Ear symptoms (tinnitus, auditory hallucinations)
  • N – Nausea, epigastric distress, vomiting
  • T – Twitching and fasciculations (classically localized to perioral, facial, or finger muscles)
  • I – Irritability, anxiety, restlessness, confusion
  • D – Dizziness, diaphoresis, dyspnea

EMERGENCY MANAGEMENT PROTOCOL: INTRA-CHAMBER SEIZURE
==================================================================================
STEP 1: IMMEDIATELY HALT 100% OXYGEN DELIVERY!
        • In a Multiplace chamber: Remove the oxygen hood or mask from the patient;
          switch to breathing chamber ambient air.
        • In a Monoplace chamber: Switch chamber gas supply to air (if equipped),
          or discontinue active pressurization.

STEP 2: MAINTAIN AIRWAY & PROTECT FROM PHYSICAL TRAUMA
        • Position the patient to prevent aspiration and blunt head injury.
        • Do not force bite blocks or instruments between clamped teeth.

STEP 3: DO NOT DECOMPRESS THE CHAMBER DURING AN ACTIVE TONIC-CLONIC SEIZURE!
        ==========================================================================
        CRITICAL PATHOPHYSIOLOGY:
        During a generalized tonic-clonic convulsion, the patient's glottis is
        tightly closed (laryngospasm / vocal cord adduction). If the chamber operator
        decompresses the chamber while the glottis is closed, the drop in ambient
        pressure causes the air trapped in the lungs to expand violently according
        to Boyle's Law (P1V1 = P2V2).
        --> This produces massive pulmonary alveolar overdistention, alveolar rupture,
            tension pneumothorax, and fatal ARTERIAL GAS EMBOLISM (AGE)!
        ==========================================================================

STEP 4: AWAIT CESSATION OF CONVULSION
        Once the seizure subsides and the patient resumes spontaneous, unobstructed
        respiratory excursions, begin slow, controlled chamber decompression to 1.0 ATA
        under direct physician supervision.
==================================================================================